Description

Retatrutide is an investigational triple agonist peptide that simultaneously targets GIP, GLP-1, and glucagon receptors. This advanced compound demonstrates potential metabolic benefits through its multi-modal mechanism of action. Designed for research purposes, it represents a significant advancement in peptide science with applications in metabolic pathway studies. Suitable for laboratory investigation by qualified researchers exploring novel therapeutic approaches.